FDA Clears New Siemens SOMATOM Perspective CT Scanner
Siemens Healthcare (NYSE: SI) has announced that the Food and Drug Administration (FDA) has cleared the SOMATOM® Perspective – an advanced 128-slice computed tomography (CT) scanner engineered to drive efficiency and reduce costs. The SOMATOM Perspective is designed especially for community hospitals, critical access hospitals and outpatient centers, offering the ability to extend the range of available examinations to their communities at reduced radiation dose in a budget-conscious environment.
The SOMATOM Perspective is an example of Siemens' approach to delivering innovative solutions that provide maximum value to customers – primary goals of the Healthcare Sector's recently announced Agenda 2013 global initiative.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.